Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I, Open-label Study to Evaluate the Pharmacokinetics and Tolerability of Ciprofloxacin in Neonates With Suspected or Proven Gram Negative Infection

NCT01319435 is registered in ClinicalTrials.gov with Liverpool Women's NHS Foundation Trust as lead sponsor.

NCT NCT01319435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01319435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I, Open-label Study to Evaluate the Pharmacokinetics and Tolerability of Ciprofloxacin in Neonates With Suspected or Proven Gram Negative Infection
Lead sponsor
Liverpool Women's NHS Foundation Trust
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2011
Completion date
November 30, 2013
Enrollment
63 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacokinetics of ciprofloxacin in neonates